SAN FRANCISCO–(BUSINESS WIRE)–Vir Biotechnology, Inc. (NASDAQ:VIR) right now introduced that Mark Eisner, M.D., M.P.H., Government Vice President and Chief Medical Officer, is scheduled to take part in a fireplace chat on the H.C. Wainwright fifth Annual Viral Hepatitis Digital Convention on Tuesday, October 8, at 10:00 a.m. PT / 1:00 p.m. ET.
A dwell webcast of the hearth chat can be made accessible underneath Occasions & Shows within the Traders part of the Vir web site at www.vir.bio and can be archived there for 30 days.
About Vir Biotechnology (NASDAQ:), Inc.
Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical firm targeted on powering the immune system to rework lives by discovering and creating medicines for severe infectious illnesses and most cancers. Vir’s clinical-stage portfolio contains infectious illness applications for power hepatitis delta and power hepatitis B infections, along with a number of oncology applications. Vir additionally has a preclinical portfolio of applications throughout a variety of different infectious illnesses and oncologic malignancies. Vir routinely posts info that could be necessary to traders on its web site.
View supply model on businesswire.com: https://www.businesswire.com/information/house/20241003019939/en/
Media
Arran Attridge
Senior Vice President, Company Communications
aattridge@vir.bio
Traders
Richard Lepke
Senior Director, Investor Relations
rlepke@vir.bio
Supply: Vir Biotechnology, Inc.
